Natural Killer Cell Biology:

For all those wishing to be briefed on the fundamentals and the latest developments in the study and understanding of NK cell biology including academics, physicians, and health personnel working in the areas of cancer, transplantation, infectious disease and immunotherapy, students at the undergraduate, graduate, and postgraduate levels working in the general area of immunology, as well as scientists in biotech or pharma involved in the development and manufacture of immunostimulatory drugs or vaccines for infectious diseases and cancer or in the area of immunosuppressive drugs for transplantation.

Lewis Lanier is an American Cancer Society Research Professor and Professor and Vice Chair, Department of Microbiology & Immunology at the University of California, San Francisco, USA. His laboratory research focuses on the human and mouse activating and inhibitory receptors that are predominantly expressed by Natural Killer (NK) cells, but are also present on subsets of effector/memory T cells and some myeloid cells. He is particularly interested in the activating NK receptors that signal by associating with two distinct signaling adapter proteins named DAP10 and DAP12. The goal of his research is to understand the role of these NK cell receptors in immune defense against tumors and microbial pathogens, and explore their potential detrimental role in autoimmune diseases.